The congenital muscular dystrophies in 2004: A century of exciting progress

Neuromuscular Disorders

Volumn 14, Issue 10, 2004, Pages 635-649

  Muntoni, Francesco ^a   Voit, Thomas ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Congenital muscular dystrophy; Dystroglycan; Extracellular matrix; Glycosylation; Neuronal migration

Indexed keywords

AGRIN; ALPHA7 INTEGRIN; COLLAGEN TYPE 6; LAMININ; MEROSIN; PERLECAN; STRUCTURAL PROTEIN;

ALLELE; ARTHROGRYPOSIS; BASEMENT MEMBRANE; CONTRACTURE; ENZYME DEFICIENCY; EXTERNAL OPHTHALMOPLEGIA; EXTRACELLULAR MATRIX; FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; GENE LOCATION; GENE MUTATION; GENETIC CODE; GENETIC COUNSELING; HUMAN; MENTAL DEFICIENCY; MUSCLE BIOPSY; MUSCLE EYE BRAIN DISEASE; MUSCLE HYPOTONIA; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PACHYGYRIA; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; TURNER SYNDROME; WALKER WARBURG SYNDROME;

BRAIN; CHROMOSOME MAPPING; DYSTROGLYCANS; GENES, DOMINANT; GLYCOPROTEINS; HUMANS; MODELS, BIOLOGICAL; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES; NERVE TISSUE PROTEINS;

EID: 4444234437     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2004.06.009     Document Type: Review

References (101)

1. F. Batten Three cases of myopathy, infantile type Brain 26 1903 147 148
2. T. Voit, and F. Tome The congenital muscular dystrophy Myolog, Engel A Ed 2004
3. V. Dubowitz 22nd ENMC sponsored workshop on congenital muscular dystrophy held in Baarn, The Netherlands, 14-16 May 1993 Neuromuscul Disord 4 1994 75 81
4. V. Dubowitz 41st ENMC international workshop on congenital muscular dystrophy 8-10 March 1996, Naarden, The Netherlands Neuromuscul Disord 6 1996 295 306
5. V. Dubowitz 50th ENMC international workshop: congenital muscular dystrophy, 28 February 1997 to 2 March 1997, Naarden, The Netherlands Neuromuscul Disord 7 1997 539 547
6. V. Dubowitz 68th ENMC international workshop (5th international workshop): on congenital muscular dystrophy, 9-11 April, Naarden, The Netherlands Neuromuscul Disord 9 1999 446 454
7. F. Muntoni, E. Bertini, and C. Bonnemann 98th ENMC international workshop on congenital muscular dystrophy (CMD), 7th workshop of the international consortium on CMD, 2nd workshop of the MYO CLUSTER project GENRE. 26-28th October, 2001, Naarden, The Netherlands Neuromuscul Disord 12 2002 889 896
8. F. Muntoni, and P. Guicheney 85th ENMC international workshop on congenital muscular dystrophy. 6th international CMD workshop. 1st workshop of the Myo-Cluster Project 'GENRE'. 27-28th October 2000, Naarden, The Netherlands Neuromuscul Disord 12 2002 69 78
9. F. Muntoni, B. Valero de Bernabe, and R. Bittner 114th ENMC international workshop on congenital muscular dystrophy (CMD) 17-19 January, Naarden, The Netherlands: (8th workshop of the international consortium on CMD; 3rd workshop of the MYO-CLUSTER project GENRE) Neuromuscul Disord 13 2003 579 588
10. M.L. Mostacciuolo, M. Miorin, F. Martinello, C. Angelini, P. Perini, and C.P. Trevisan Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy Hum Genet 97 1996 277 279
11. F.M. Tome, T. Evangelista, and A. Leclerc Congenital muscular dystrophy with merosin deficiency C R Acad Sci III 317 1994 351 357
12. D. Hillaire, A. Leclerc, and S. Faure Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping Hum Mol Genet 3 1994 1657 1661
13. A. Helbling-Leclerc, X. Zhang, and H. Topaloglu Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy Nat Genet 11 1995 216 218
14. E. Engvall Laminin variants: why, where and when? Kidney Int 43 1993 2 6
15. D. Gullberg, C.F. Tiger, and T. Velling Laminins during muscle development and in muscular dystrophies Cell Mol Life Sci 56 1999 442 460
16. P.H.L.F. Vachon, and H. Xu Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival J Cell Biol 134 1996 1483 1497
17. H. Colognato, and P.D. Yurchenco The laminin alpha2 expressed by dystrophic dy(2J) mice is defective in its ability to form polymers Curr Biol 9 1999 1327 1330
18. J. Philpot, C. Sewry, J. Pennock, and V. Dubowitz Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle Neuromuscul Disord 5 1995 301 305
19. J. Philpot, and F. Muntoni Limitation of eye movement in merosin-deficient congenital muscular dystrophy Lancet 353 1999 297 298
20. J. Philpot, A. Bagnall, C. King, V. Dubowitz, and F. Muntoni Feeding problems in merosin deficient congenital muscular dystrophy Arch Dis Child 80 1999 542 547
21. H.J. Gilhuis, H.J. ten Donkelaar, and R.B. Tanke Nonmuscular involvement in merosin-negative congenital muscular dystrophy Pediatr Neurol 26 2002 30 36
22. N. Spyrou, J. Philpot, R. Foale, P.G. Camici, and F. Muntoni Evidence of left ventricular dysfunction in children with merosin-deficient congenital muscular dystrophy Am Heart J 136 1998 474 476
23. M. Villanova, A. Malandrini, and P. Sabatelli Localization of laminin alpha 2 chain in normal human central nervous system: an immunofluorescence and ultrastructural study Acta Neuropathol (Berl) 94 1997 567 571
24. P.C. Buttery, and C. Ffrench-Constant Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes Mol Cell Neurosci 14 1999 199 212
25. J. Philpot, H. Topaloglu, J. Pennock, and V. Dubowitz Familial concordance of brain magnetic resonance imaging changes in congenital muscular dystrophy Neuromuscul Disord 5 1995 227 231
26. Y. Sunada, T.S. Edgar, B.P. Lotz, R.S. Rust, and K.P. Campbell Merosin-negative congenital muscular dystrophy associated with extensive brain abnormalities Neurology 45 1995 2084 2089
27. J. Philpot, F. Cowan, and J. Pennock Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging Neuromuscul Disord 9 1999 81 85
28. R. Herrmann, V. Straub, K. Meyer, T. Kahn, M. Wagner, and T. Voit Congenital muscular dystrophy with laminin alpha 2 chain deficiency: identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistry Eur J Pediatr 155 1996 968 976
29. E. Mercuri, F. Muntoni, and A. Berardinelli Somatosensory and visual evoked potentials in congenital muscular dystrophy: correlation with MRI changes and muscle merosin status Neuropediatrics 26 1995 3 7
30. Z. Shorer, J. Philpot, F. Muntoni, C. Sewry, and V. Dubowitz Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy J Child Neurol 10 1995 472 475
31. E. Engvall, and U.M. Wewer Domains of laminin J Cell Biochem 61 1996 493 501
32. R.A. Kammerer, T. Schultheiss, and R. Landwehr Interaction of agrin with laminin requires a coiled-coil conformation of the agrin-binding site within the laminin gamma1 chain Eur Mol Biol Org J 18 1999 6762 6770
33. P.D. Yurchenco, Y.S. Cheng, K. Campbell, and S. Li Loss of basement membrane, receptor and cytoskeletal lattices in a laminin-deficient muscular dystrophy J Cell Sci 117 2004 735 742
34. R.D. Cohn, R. Herrmann, U.M. Wewer, and T. Voit Changes of laminin beta 2 chain expression in congenital muscular dystrophy Neuromuscul Disord 7 1997 373 378
35. R.D. Cohn, U. Mayer, and G. Saher Secondary reduction of alpha7B integrin in laminin alpha2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle J Neurol Sci 163 1999 140 152
36. C.A. Sewry, J. Philpot, D. Mahony, L.A. Wilson, F. Muntoni, and V. Dubowitz Expression of laminin subunits in congenital muscular dystrophy Neuromuscul Disord 5 1995 307 316
37. V. Allamand, and P. Guicheney Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin) Eur J Hum Genet 10 2002 91 94
38. I. Naom, M. D'Alessandro, and C. Sewry The role of immunocytochemistry and linkage analysis in the prenatal diagnosis of merosin-deficient congenital muscular dystrophy Hum Genet 99 1997 535 540
39. P. Guicheney, N. Vignier, and X. Zhang PCR based mutation screening of the laminin alpha2 chain gene (LAMA2): application to prenatal diagnosis and search for founder effects in congenital muscular dystrophy J Med Genet 35 1998 211 217
40. E. Pegoraro, P. Mancias, and S.H. Swerdlow Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy Ann Neurol 40 1996 782 791
41. C.A. Sewry, I. Naom, and M. D'Alessandro Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin alpha 2 chain Neuromuscul Disord 7 1997 169 175
42. R.D. Cohn, R. Herrmann, L. Sorokin, U.M. Wewer, and T. Voit Laminin alpha2 chain-deficient congenital muscular dystrophy: variable epitope expression in severe and mild cases Neurology 51 1998 94 100
43. C.A. Sewry, J. Philpot, and L.M. Sorokin Diagnosis of merosin (laminin-2) deficient congenital muscular dystrophy by skin biopsy Lancet 347 1996 582 584
44. K. Bushby, L.V. Anderson, and C. Pollit: Abnormal merosin in adults. A new form of late onset muscular dystrophy not linked to chromosome 6q2 Brain 121 1998 581 588
45. M. Brockington, Y. Yuva, and P. Prandini Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C Hum Mol Genet 10 2001 2851 2859
46. E. Tan, H. Topaloglu, and C. Sewry Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency Neuromuscul Disord 7 1997 85 89
47. M. Nissinen, A. Helbling-Leclerc, and X. Zhang Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin alpha2-chain in congenital muscular dystrophy with partial deficiency of the protein Am J Hum Genet 58 1996 1177 1184
48. O. Ullrich Kongenitale, atonisch-sklerotische Muskeldystrophie Monatsschr Kinderheilkd 47 1930 502 510
49. R.Z. Zhang, P. Sabatelli, and T.C. Pan Effects on collagen VI mRNA stability and microfibrillar assembly of three COL6A2 mutations in two families with Ullrich congenital muscular dystrophy J Biol Chem 277 2002 43557 43564
50. O. Camacho Vanegas, E. Bertini, and R.Z. Zhang Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI Proc Natl Acad Sci USA 98 2001 7516 7521
51. H. Ishikawa, K. Sugie, and K. Murayama Ullrich disease: collagen VI deficiency: EM suggests a new basis for muscular weakness Neurology 59 2002 920 923
52. T.C. Pan, R.Z. Zhang, D.G. Sudano, S.K. Marie, C.G. Bonnemann, and M.L. Chu New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype Am J Hum Genet 73 2003 355 369
53. W.A. Irwin, N. Bergamin, and P. Sabatelli Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency Nat Genet 35 2003 367 371
54. H. Ishikawa, K. Sugie, and K. Murayama Ullrich disease due to deficiency of collagen VI in the sarcolemma Neurology 62 2004 620 623
55. E. Mercuri, C. Cini, and A. Pichiecchio Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotype Neuromuscul Disord 13 2003 554 558
56. P.H. Vachon, H. Xu, and L. Liu Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy J Clin Invest 100 1997 1870 1881
57. Y.K. Hayashi, F.L. Chou, and E. Engvall Mutations in the integrin alpha7 gene cause congenital myopathy Nat Genet 19 1998 94 97
58. E. Pegoraro, F. Cepollaro, and P. Prandini Integrin alpha 7 beta 1 in muscular dystrophy/myopathy of unknown etiology Am J Pathol 160 2002 2135 2143
59. D.E. Michele, and K.P. Campbell Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function J Biol Chem 278 2003 15457 15460
60. T. Endo, and T. Toda Glycosylation in congenital muscular dystrophies Biol Pharm Bull 26 2003 1641 1647
61. M.D. Henry, and K.P. Campbell Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton Curr Opin Cell Biol 1996 8
62. R.D. Cohn, M.D. Henry, and D.E. Michele: Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration Cell 110 2002 639 648
63. D.E. Michele, R. Barresi, and M. Kanagawa Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies Nature 418 2002 417 422
64. F. Muntoni, M. Brockington, S. Torelli, and S.C. Brown Defective glycosylation on congenital muscular dystrophies Curr Opin Neurol 17 2 2004 205 209
65. Y. Fukuyama, M. Kwazura, and H. Haruna A peculiar form of congenital muscular dystrophy Paediatr Univ Tokyo 4 1960 5 8
66. M. Osawa, S. Sumida, and N. Suzuki Fukuyama type congenital muscular dystrophy Y. Fukuyama M. Osawa K. Saito Congenital muscular dystrophies 1997 Elsevier Amsterdam 31 68
67. K. Kobayashi, Y. Nakahori, and M. Miyake An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy Nature 394 1998 388 392
68. F. Silan, M. Yoshioka, and K. Kobayashi A new mutation of the fukutin gene in a non-Japanese patient Ann Neurol 53 2003 392 396
69. D.B. de Bernabe, H. van Bokhoven, and E. van Beusekom A homozygous nonsense mutation in the fukutin gene causes a Walker-Warburg syndrome phenotype J Med Genet 40 2003 845 848
70. Y.K. Hayashi, M. Ogawa, and K. Tagawa Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy Neurology 57 2001 115 121
71. T. Yamamoto, Y. Kato, and M. Karita Fukutin expression in glial cells and neurons: implication in the brain lesions of Fukuyama congenital muscular dystrophy Acta Neuropathol (Berl) 104 2002 217 224
72. S.A. Moore, F. Saito, and J. Chen Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy Nature 418 2002 422 425
73. Y. Saito, M. Kobayashi, and M. Itoh Aberrant neuronal migration in the brainstem of fukuyama-type congenital muscular dystrophy J Neuropathol Exp Neurol 62 2003 497 508
74. P. Santavuori, J. Leisti, and S. Kruus Muscle, eye and brain disease: a new syndrome Neuropädiatrie 8 1977 550
75. M. Haltia, I. Leivo, and H. Somer Muscle-eye-brain disease: a neuropathological study Ann Neurol 41 1997 173 180
76. A. Yoshida, K. Kobayashi, and H. Manya Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1 Dev Cell 1 2001 717 724
77. K. Taniguchi, K. Kobayashi, and K. Saito Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease Hum Mol Genet 12 2003 527 534
78. H. Manya, K. Sakai, and K. Kobayashi Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease Biochem Biophys Res Commun 306 2003 93 97
79. W. Zhang, J. Vajsar, and P. Cao Enzymatic diagnostic test for muscle-eye-brain type congenital muscular dystrophy using commercially available reagents Clin Biochem 36 2003 339 344
80. H. Kano, K. Kobayashi, and R. Herrmann Deficiency of alpha-dystroglycan in muscle-eye-brain disease Biochem Biophys Res Commun 291 2002 1283 1286
81. A.E. Walker Lissencephaly Arch Neurol Psychol 48 1942 13 29
82. M. Warburg Hydrocephaly, congenital retinal nonattachment, and congenital falciform fold Am J Ophthalmol 85 1978 88 94
83. W.B. Dobyns, R.A. Pagon, and D. Armstrong Diagnostic criteria for Walker-Warburg syndrome Am J Med Genet 32 1989 195 210
84. D. Beltran-Valero de Bernabe, S. Currier, and A. Steinbrecher Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome Am J Hum Genet 71 2002 1033 1043
85. T. Willer, M.C. Valero, W. Tanner, J. Cruces, and S. Strahl O-mannosyl glycans: from yeast to novel associations with human disease Curr Opin Struct Biol 13 2003 621 630
86. H. Manya, A. Chiba, and A. Yoshida Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity Proc Natl Acad Sci USA 101 2004 500 505
87. C. Jimenez-Mallebrera, S. Torelli, and S.C. Brown Profound skeletal muscle depletion of alpha-dystroglycan in Walker-Warburg syndrome Eur J Paediatr Neurol 7 2003 129 137
88. E. Mercuri, C.A. Sewry, and S.C. Brown Congenital muscular dystrophy with secondary merosin deficiency and normal brain MRI: a novel entity? Neuropediatrics 31 2000 186 189
89. H. Topaloglu, M. Brockington, and Y. Yuva FKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts Neurology 60 2003 988 992
90. A. Driss, S. Noguchi, and R. Amouri Fukutin-related protein gene mutated in the original kindred limb-girdle MD 2I Neurology 60 2003 1341 1344
91. D. Beltrán Valero de Bernabé, T. Voit, and C. Longman Mutations in the FKRP gene can cause Muscle-Eye-Brain disease and Walker-Warburg syndrome J Med Genet 41 2004 61 66
92. E. Mercuri, M. Brockington, and V. Straub Phenotypic spectrum associated with mutations in the fukutin-related protein gene Ann Neurol 53 2003 537 542
93. M. Poppe, L. Cree, and J. Bourke The phenotype of limb-girdle muscular dystrophy type 2I Neurology 60 2003 1246 1251
94. M. Brockington, D.J. Blake, and P. Prandini Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan Am J Hum Genet 69 2001 1198 1209
95. S.C. Brown, S. Torelli, and M. Brockington Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies Am J Pathol 164 2004 727 737
96. C. Longman, M. Brockington, and S. Torelli Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan Hum Mol Genet 12 2003 2853 2861
97. V. Dubowitz Rigid spine syndrome: a muscle syndrome in search of a name Proc R Soc Med 66 1973 219 220
98. B. Moghadaszadeh, N. Petit, and C. Jaillard Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome Nat Genet 29 2001 17 18
99. N. Petit, A. Lescure, and M. Rederstorff an endoplasmic reticulum glycoprotein with an early developmental expression pattern Hum Mol Genet 12 2003 1045 1053
100. A. Ferreiro, S. Quijano-Roy, and C. Pichereau Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies Am J Hum Genet 71 2002 739 749
101. A. Ferreiro, C. Ceuterick-de Groote, and J.J. Marks Desmin-related myopathy with mallory body-like inclusions is caused by mutations of the selenoprotein N gene Ann Neurol 55 2004 676 686